Product Details for: Tecentriq Hybreza

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
1,875MG/15ML; 30,000UNITS/15ML (125MG/2,000UNITS/ML)
Single-Dose Vial
351(a)
Tecentriq Hybreza
Rx
Proper Name
atezolizumab and hyaluronidase-tqjs
BLA Number
761347
Applicant
Genentech, Inc.
Original Approval Date
September 12, 2024
Date of First Licensure
RETURN TO SEARCH RESULTS